Aeglea Competitors and Similar CompaniesClear all
Aeglea's competitors and similar companies include Orphan Technologies and PHAXIAM Therapeutics.
 Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  PHAXIAM Therapeutics PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors. | ||
Founding Date | Founding Date 2013 | Founding Date N/A | Founding Date 2004 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Austin, US HQ | Locations Rapperswil-Jona, CH HQ | Locations Lyon, FR HQ Cambridge, US Princeton, US |
Employees | Employees 65117% increase | Employees 1 | Employees 49 |
Valuation ($) | Valuation ($) 48.6 m | Valuation ($) N/A | Valuation ($) 52.8 m |
Financial | |||
Net income | Net income ($155.2m) (FY, 2025) | Net income N/A | Net income (€23.5m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Orphan Technologies
HQ
Rapperswil-Jona, CH
Employees
1
Orphan Technologies is a biotech company developing a drug for homocystinuria.
View companyPHAXIAM Therapeutics
HQ
Lyon, FR
Employees
49
PHAXIAM Therapeutics (formerly known as Erytech Pharma) is a biopharmaceutical company that develops enzyme-based medicinal products for the oncology, hematology, and immunology sectors.
View company